These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9614724)

  • 1. Interferon beta-1A for multiple sclerosis.
    Drug Ther Bull; 1998 Jan; 36(1):7-8. PubMed ID: 9614724
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon beta-1b for the treatment of multiple sclerosis.
    Petri T; Weber-Diehl F
    J Biotechnol; 1995 Nov; 43(1):74-5. PubMed ID: 8573325
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon beta-1B--hope or hype?
    Drug Ther Bull; 1996 Feb; 34(2):9-11. PubMed ID: 8819985
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon beta-1a in relapsing-remitting multiple sclerosis.
    Blumhardt L
    Hosp Med; 1999 Mar; 60(3):192-5. PubMed ID: 10476242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon beta-1b.
    Goodkin DE
    Lancet; 1994 Oct; 344(8929):1057-60. PubMed ID: 7934448
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of multiple sclerosis with interferon beta-1 b.
    Abdul-Ahad A; Shah S; Galazka A
    Neurology; 1997 Aug; 49(2):641-2. PubMed ID: 9270626
    [No Abstract]   [Full Text] [Related]  

  • 7. Appropriate design and outcome measures in multiple sclerosis clinical trials.
    Greenstein JI
    Eur J Neurol; 2001 Sep; 8(5):503-6. PubMed ID: 11554918
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon beta-1b.
    Rudge P
    Lancet; 1994 Nov; 344(8935):1511. PubMed ID: 7968150
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
    Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatments for multiple sclerosis.
    McDonald WI
    BMJ; 1995 Feb; 310(6976):345-6. PubMed ID: 7866205
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Rudick RA; Goodkin DE; Jacobs LD; Cookfair DL; Herndon RM; Richert JR; Salazar AM; Fischer JS; Granger CV; Simon JH; Alam JJ; Simonian NA; Campion MK; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Whitham RH
    Neurology; 1997 Aug; 49(2):358-63. PubMed ID: 9270562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of multiple sclerosis using recombinant interferon-beta].
    Polman CH; Barkhof F; van Loenen AC; Lucas CJ; Koetsier JC
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):7-10. PubMed ID: 8289963
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial of interferon-beta in multiple sclerosis stopped early.
    Bonn D
    Lancet; 1998 Feb; 351(9102):573. PubMed ID: 9492786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
    Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary myelin basic protein-like material in patients with multiple sclerosis during interferon beta-1b treatment.
    Whitaker JN; Layton BA; Bartolucci AA; Mitchell GW; Bashir K; Goodwin J; Kachelhofer RD
    Arch Neurol; 1999 Jun; 56(6):687-91. PubMed ID: 10369307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
    Longthorne PN
    BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939141
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
    Cardy P
    BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939142
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon beta in multiple sclerosis.
    Richards RG
    BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of interferons in demyelinating disease.
    Johnson KP
    J Neural Transm Suppl; 1997; 49():111-5. PubMed ID: 9266420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.